StockData
Pulse Biosciences, Inc. logo

Pulse Biosciences, Inc. (PLSE) stock

PLSENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$44.84−1.52 (-3.28%)

Close on Nov 17, 2026Market cap $3.20BP/E –Yield –

Pulse Biosciences total assets

Total assets on the balance sheet at the end of each period.

Pulse Biosciences's total assets was $115.56M at Jun 30, 2026. For fiscal 2025 it was $94.54M, down 28.6% from the year before. Over ten years it grew 20.8% a year on average. The highest annual figure on record is $132.46M in fiscal 2024.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$94.54M-28.6%
FY2024Dec 31, 2024$132.46M+123.9%
FY2023Dec 31, 2023$59.15M-24.0%
FY2022Dec 31, 2022$77.88M+31.7%
FY2021Dec 31, 2021$59.15M+43.3%
FY2020Dec 31, 2020$41.29M-1.5%
FY2019Dec 31, 2019$41.92M-40.7%
FY2018Dec 31, 2018$70.64M+41.8%
FY2017Dec 31, 2017$49.82M+89.3%
FY2016Dec 31, 2016$26.31M+83.7%
FY2015Dec 31, 2015$14.33M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$115.56M-3.9%
Q1 FY2026Mar 31, 2026$81.62M-38.8%
Q4 FY2025Dec 31, 2025$94.54M-28.6%
Q3 FY2025Sep 30, 2025$108.77M+16.9%
Q2 FY2025Jun 30, 2025$120.25M+197.4%
Q1 FY2025Mar 31, 2025$133.38M+171.3%
Q4 FY2024Dec 31, 2024$132.46M+123.9%
Q3 FY2024Sep 30, 2024$93.05M+41.1%
Q2 FY2024Jun 30, 2024$40.43M-45.9%
Q1 FY2024Mar 31, 2024$49.16M-30.0%
Q4 FY2023Dec 31, 2023$59.15M-24.0%
Q3 FY2023Sep 30, 2023$65.95M-24.7%
Q2 FY2023Jun 30, 2023$74.76M+84.1%
Q1 FY2023Mar 31, 2023$70.22M+77.6%
Q4 FY2022Dec 31, 2022$77.88M+31.7%
Q3 FY2022Sep 30, 2022$87.57M+30.4%
Q2 FY2022Jun 30, 2022$40.60M-49.3%
Q1 FY2022Mar 31, 2022$39.53M-50.9%
Q4 FY2021Dec 31, 2021$59.15M+43.3%
Q3 FY2021Sep 30, 2021$67.15M+35.1%
Q2 FY2021Jun 30, 2021$80.04M+37.1%
Q1 FY2021Mar 31, 2021$80.56M+153.0%
Q4 FY2020Dec 31, 2020$41.29M-1.5%
Q3 FY2020Sep 30, 2020$49.70M+2.0%
Q2 FY2020Jun 30, 2020$58.38M+2.4%
Q1 FY2020Mar 31, 2020$31.84M-49.8%
Q4 FY2019Dec 31, 2019$41.92M-40.7%
Q3 FY2019Sep 30, 2019$48.70M+48.8%
Q2 FY2019Jun 30, 2019$57.03M+44.3%
Q1 FY2019Mar 31, 2019$63.45M+41.6%
Q4 FY2018Dec 31, 2018$70.64M+41.8%
Q3 FY2018Sep 30, 2018$32.73M-39.5%
Q2 FY2018Jun 30, 2018$39.53M+41.4%
Q1 FY2018Mar 31, 2018$44.80M+56.8%
Q4 FY2017Dec 31, 2017$49.82M+89.3%
Q3 FY2017Sep 30, 2017$54.12M+87.7%
Q2 FY2017Jun 30, 2017$27.95M–
Q1 FY2017Mar 31, 2017$28.57M–
Q4 FY2016Dec 31, 2016$26.31M–
Q3 FY2016Sep 30, 2016$28.83M–

More Pulse Biosciences figures

See a number that looks wrong?